Last reviewed 2026-04-20 · How we verify

prescribing anapproved drug, examination

I.M. Sechenov First Moscow State Medical University · FDA-approved active Small molecule Quality 2/100

prescribing anapproved drug, examination is a Small molecule drug developed by I.M. Sechenov First Moscow State Medical University. It is currently FDA-approved. Also known as: Trimedate, Rebagit.

At a glance

Generic name	prescribing anapproved drug, examination
Also known as	Trimedate, Rebagit
Sponsor	I.M. Sechenov First Moscow State Medical University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

prescribing anapproved drug, examination CI brief — competitive landscape report
prescribing anapproved drug, examination updates RSS · CI watch RSS
I.M. Sechenov First Moscow State Medical University portfolio CI

Frequently asked questions about prescribing anapproved drug, examination

What is prescribing anapproved drug, examination?

prescribing anapproved drug, examination is a Small molecule drug developed by I.M. Sechenov First Moscow State Medical University.

Who makes prescribing anapproved drug, examination?

prescribing anapproved drug, examination is developed and marketed by I.M. Sechenov First Moscow State Medical University (see full I.M. Sechenov First Moscow State Medical University pipeline at /company/i-m-sechenov-first-moscow-state-medical-university).

Is prescribing anapproved drug, examination also known as anything else?

prescribing anapproved drug, examination is also known as Trimedate, Rebagit.

What development phase is prescribing anapproved drug, examination in?

prescribing anapproved drug, examination is FDA-approved (marketed).

Manufacturer: I.M. Sechenov First Moscow State Medical University — full pipeline
Also known as: Trimedate, Rebagit
Compare: prescribing anapproved drug, examination vs similar drugs
Pricing: prescribing anapproved drug, examination cost, discount & access